D-0070-2023 Class III Terminated
FDA drug recall D-0070-2023 was initiated by Acella Pharmaceuticals, LLC on Nov 14, 2022 and is designated Class III. Reason for recall: Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode. The recall status is terminated (terminated Aug 21, 2024). Affected quantity: 637 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 30, 2022
- Initiation Date
- Nov 14, 2022
- Termination Date
- Aug 21, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 637 cartons
Product description
Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005
Reason for recall
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Distribution pattern
Nationwide in the USA.
Code information
Lot: E026A001 Exp. 06/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0070-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026